Psychiatric disorders induced by drug and plant toxicity represent a complex and underexplored area in medical research. Exposure to substances such as pharmaceuticals, illicit drugs, and environmental toxins can trigger a wide range of neuropsychiatric symptoms. This study proposes the development of a machine learning (ML) model to predict and classify these symptoms by analyzing open-access, de-identified datasets. Supervised and unsupervised learning techniques, including neural networks and algorithms like XGBoost, were applied to distinguish drug-induced psychiatric conditions from primary psychiatric disorders. The models were evaluated using metrics such as accuracy, precision, recall, and AUC-ROC. The XGBoost model demonstrated the best performance, achieving an AUC-ROC of 94.8%, making it a promising tool for clinical decision-support systems. This approach can improve early detection and intervention for psychiatric symptoms associated with drug toxicity, contributing to safer and more personalized healthcare.
No takes yet. Share an insight, caveat, or question.
Wahed et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: